FIELD: medicine.
SUBSTANCE: invention belongs to medicine, notably to oncology, and can be used in prevention and treatment of enteropathy due to intensive cytostatic polychemotherapy. To achieve this Enterosgel (Methylsiliconic acid hydrogel) is administered during whole course of polychemotherapy and after it. After cytostatic treatment during Enterosgel administration additionally nonabsorbable enteral antiseptic ersefuril is administered. normobiotics - Hylac-forte and Primadophilus™ Bifidus are administered when level of leukocytes in blood gets higher then 1000/mcl.
EFFECT: method ensures prevention of necrotic processes, reparation of gastro-intestinal mucous lining and fast arresting of enteropathy due to toxic metabolites enterosorption, elimination of pathogenic and opportunistic microbes and regulation of intestinal flora balance.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS WITH INTESTINAL DYSBACTERIOSIS | 2009 |
|
RU2400235C1 |
| METHOD OF TREATING INTESTINAL DYSBACTERIOSIS | 2009 |
|
RU2397773C1 |
| AGENT FOR CORRECTING DYSPEPTIC DISORDERS OF THE GASTROINTESTINAL TRACT | 2020 |
|
RU2755707C1 |
| METHOD FOR TREATMENT OF DYSBACTERIOSIS OF DIFFERENT ETIOLOGY, AMONG THEM, ACUTE INTESTINAL INFECTIONS | 2002 |
|
RU2230564C2 |
| METHOD FOR ORAL MICROBIOTA CORRECTION IN ADULTS AND CHILDREN WITH INTESTINAL PROTOZOAL INFECTIONS | 2023 |
|
RU2813945C1 |
| METHOD FOR PREVENTION OF DIALYSIS PERITONITES | 2008 |
|
RU2379045C1 |
| METHOD FOR ACCOMPANYING TREATMENT OF LYMPHOBLAST LEUCOSIS | 2006 |
|
RU2320367C1 |
| METHOD OF TREATING PATIENTS WITH INTESTINAL DISBACTERIOSIS | 2014 |
|
RU2571495C1 |
| METHOD FOR COMPLEX CORRECTION OF INTESTINAL DYSBIOSIS WITH THE HELP OF LIQUID PROBIOTIC "NARINE-FORTE" AND PREBIOTIC SYRUP "PHYTOLON" WITH CHLOROPHYLL | 2005 |
|
RU2322251C2 |
| SET FOR DYSBACTERIOSIS TREATMENT AND TREATMENT METHOD | 2005 |
|
RU2365376C2 |
